Abiopharma

IQVIA - IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4

Natera - Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium

Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

Amneal to Participate in Upcoming Investor Conferences

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

Curaleaf Enters into an Equity Purchase Agreement for the Virginia Assets of The Cannabist Company

Changes to the Composition of the Board and Board Committees

Change - Announcement of Appointment :: Appointment of Non-Independent Non-Executive Chairman